These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2239930)

  • 1. Cyclosporine nephrotoxicity and the role of cyclosporine in living-related donor transplantation.
    Paller MS
    Am J Kidney Dis; 1990 Nov; 16(5):414-6. PubMed ID: 2239930
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor specific transfusions or cyclosporine for related-donor kidney transplantation?
    Jayes RL; Levey AS
    Kidney Int; 1989 Sep; 36(3):485-96. PubMed ID: 2593493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of donor age and sex on cyclosporine associated nephrotoxicity.
    Iguro T; Okazaki H; Sato T; Jimbo M; Oguma S
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1554-5. PubMed ID: 2652504
    [No Abstract]   [Full Text] [Related]  

  • 4. Baseline biopsies define cyclosporine nephrotoxicity.
    Belnap LP; Hammond EH; Yowell R; Richards KF; Rees WV; Stevens LE
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1485. PubMed ID: 2652476
    [No Abstract]   [Full Text] [Related]  

  • 5. [Is nephrotoxicity of cyclosporine ineluctable?].
    Niaudet P
    Presse Med; 1994 Jun; 23(23):1061-3. PubMed ID: 7971816
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic irreversible nephrotoxicity from cyclosporin A.
    Rao KV; Crosson JT; Kjellstrand CM
    Nephron; 1985; 41(1):75-7. PubMed ID: 3897887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation?
    Kumar MS; Samhan M; John P; al-Adnani MS; Abouna GM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1552-3. PubMed ID: 2652503
    [No Abstract]   [Full Text] [Related]  

  • 8. The spectrum of ciclosporin nephrotoxicity.
    Puschett JB; Greenberg A; Holley J; McCauley J
    Am J Nephrol; 1990; 10(4):296-309. PubMed ID: 2240057
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of cyclosporine on long-term function in patients undergoing kidney transplant from living donors.
    Alfani D; Berloco P; Renna Molajoni E; Pretagostini R; Famulari A; Sallustio F; Caricato M; Rossi M; Pecorella I; Ciardi A
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1759-60. PubMed ID: 3274421
    [No Abstract]   [Full Text] [Related]  

  • 10. Nephrotoxicity of a nonionic (iopamidol) versus an ionic (diatrizoate) contrast agent in the patient after cardiac transplant with moderate cyclosporine-induced renal insufficiency.
    Denys BG; Reddy PS; Uretsky BF
    Am J Cardiol; 1989 Aug; 64(5):405-6. PubMed ID: 2667306
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic nephrotoxicity complicating cyclosporine treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Kolkin S; Nahman NS; Mendell JR
    Neurology; 1987 Jan; 37(1):147-9. PubMed ID: 3796829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for cadaveric donor allograft survival in cyclosporine-prednisone-treated recipients.
    Kahan BD; Mickey R; Flechner SM; Lorber MI; Wideman CA; Kerman RH; Terasaki P; Van Buren CT
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1835-8. PubMed ID: 3547890
    [No Abstract]   [Full Text] [Related]  

  • 13. The case against the indefinite use of cyclosporine.
    Myers BD; Newton L; Oyer P
    Transplant Proc; 1991 Feb; 23(1 Pt 1):41-2. PubMed ID: 1990570
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine nephropathy after heart and heart-lung transplantation.
    Goldstein J; Thoua Y; Wellens F; Leclerc JL; Vanherweghem JL; Vereerstraeten P; Primo G; Toussaint C
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():973-81. PubMed ID: 3921960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine-induced nephrotoxicity: pathophysiology of decreased blood flow.
    Curtis JJ; Laskow DA
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):540-3. PubMed ID: 3388498
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized clinical trial of cyclosporine or donor specific transfusions in high risk living-related donor transplantation.
    Bordes-Aznar J; Odor A; Dib-Kuri A; Gabilondo F; Kasep J; Peña JC; Herrera-Acosta J; Chávez-Peón F
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2276-7. PubMed ID: 3079080
    [No Abstract]   [Full Text] [Related]  

  • 17. Early and late complications of cyclosporine treatment in a 5-year follow-up of 250 renal transplant recipients.
    Civati G; Busnach G; Perrino ML; Broggi ML; Brando B; Seveso M; Minetti L
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1571-2. PubMed ID: 2652510
    [No Abstract]   [Full Text] [Related]  

  • 18. "Cyclosporine-A nephrotoxicity in renal allograft recipients".
    Nix K; Plawecki HM
    J Nephrol Nurs; 1985; 2(5):220-2. PubMed ID: 3903104
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine nephrotoxicity.
    Barton CH; Vaziri ND
    Int J Artif Organs; 1985 Nov; 8(6):291-6. PubMed ID: 4077286
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for the development of chronic cyclosporine-nephrotoxicity.
    Mihatsch MJ; Steiner K; Abeywickrama KH; Landmann J; Thiel G
    Clin Nephrol; 1988 Apr; 29(4):165-75. PubMed ID: 3284669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.